Insights into mitochondrial dysfunction: aging, amyloid-β, and tau-A deleterious trio.
暂无分享,去创建一个
[1] P. Reddy,et al. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. , 2011, Human molecular genetics.
[2] R. Swerdlow,et al. Brain aging, Alzheimer's disease, and mitochondria. , 2011, Biochimica et biophysica acta.
[3] P. Reddy,et al. Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics. , 2011, Biochimica et biophysica acta.
[4] P. Reddy,et al. Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease , 2011, Brain Research.
[5] P. Reddy,et al. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. , 2011, Human molecular genetics.
[6] J. Götz,et al. Mitochondrial dysfunction - the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-β toxicity , 2011, Alzheimer's Research & Therapy.
[7] Lucia Pagani,et al. Amyloid-Beta Interaction with Mitochondria , 2011, International journal of Alzheimer's disease.
[8] L. Lue,et al. Inhibition of Amyloid-β (Aβ) Peptide-Binding Alcohol Dehydrogenase-Aβ Interaction Reduces Aβ Accumulation and Improves Mitochondrial Function in a Mouse Model of Alzheimer's Disease , 2011, The Journal of Neuroscience.
[9] Jürgen Götz,et al. Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease , 2011, Nature Reviews Neuroscience.
[10] B. Winblad,et al. Mitochondrial γ‐secretase participates in the metabolism of mitochondria‐associated amyloid precursor protein , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] Jürgen Götz,et al. Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.
[12] Kaihua Guo,et al. Ginkgo biloba extract EGb761 protects against aging-associated mitochondrial dysfunction in platelets and hippocampi of SAMP8 mice , 2010, Platelets.
[13] D. Wallace,et al. Mitochondrial DNA mutations in disease and aging , 2010, Environmental and molecular mutagenesis.
[14] M. Guilhaus,et al. Aβ and human amylin share a common toxicity pathway via mitochondrial dysfunction , 2010, Proteomics.
[15] J. Strosznajder,et al. Cyclic GMP and Nitric Oxide Synthase in Aging and Alzheimer's Disease , 2010, Molecular Neurobiology.
[16] J. Götz,et al. Convergence of Amyloid-β and Tau Pathologies on Mitochondria In Vivo , 2010, Molecular Neurobiology.
[17] L. Ozmen,et al. Phosphorylation of Tau at S422 is enhanced by Aβ in TauPS2APP triple transgenic mice , 2010, Neurobiology of Disease.
[18] M. Jendrach,et al. Mitochondrial dysfunction: An early event in Alzheimer pathology accumulates with age in AD transgenic mice , 2009, Neurobiology of Aging.
[19] M. Ankarcrona,et al. Mitochondrial accumulation of APP and Aβ: significance for Alzheimer disease pathogenesis , 2009, Journal of cellular and molecular medicine.
[20] R. Hamilton,et al. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease , 2009, Proceedings of the National Academy of Sciences.
[21] I. Poser,et al. SR protein family members display diverse activities in the formation of nascent and mature mRNPs in vivo. , 2009, Molecular cell.
[22] M. Mattson,et al. Mitochondria in Neuroplasticity and Neurological Disorders , 2008, Neuron.
[23] J. Nilsen. Estradiol and neurodegenerative oxidative stress , 2008, Frontiers in Neuroendocrinology.
[24] M. Fändrich,et al. Oligomeric and fibrillar species of β-amyloid (Aβ42) both impair mitochondrial function in P301L tau transgenic mice , 2008, Journal of Molecular Medicine.
[25] Xiongwei Zhu,et al. Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients. , 2008, The American journal of pathology.
[26] José A. García,et al. Improved mitochondrial function and increased life span after chronic melatonin treatment in senescent prone mice , 2008, Experimental Gerontology.
[27] J. Götz,et al. Animal models of Alzheimer's disease and frontotemporal dementia , 2008, Nature Reviews Neuroscience.
[28] A. Eckert,et al. Dose-dependent and sequence-sensitive effects of amyloid-β peptide on neurosteroidogenesis in human neuroblastoma cells , 2008, Neurochemistry International.
[29] J. Götz,et al. Soluble Beta-Amyloid Leads to Mitochondrial Defects in Amyloid Precursor Protein and Tau Transgenic Mice , 2008, Neurodegenerative Diseases.
[30] M. Beal,et al. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. , 2008, Trends in molecular medicine.
[31] M. Staufenbiel,et al. Induction of Tau Pathology by Intracerebral Infusion of Amyloid-β-Containing Brain Extract and by Amyloid-β Deposition in APP × Tau Transgenic Mice , 2007 .
[32] Jie Xu,et al. Mitochondrial dysfunction in platelets and hippocampi of senescence-accelerated mice , 2007, Journal of bioenergetics and biomembranes.
[33] N. Kraut,et al. Proteomic and functional alterations in brain mitochondria from Tg2576 mice occur before amyloid plaque deposition , 2007, Proteomics.
[34] Jürgen Götz,et al. β‐Amyloid treatment of two complementary P301L tau‐expressing Alzheimer's disease models reveals similar deregulated cellular processes , 2006, Proteomics.
[35] J. Götz,et al. Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease? , 2006, Journal of neurochemistry.
[36] J. Quinn,et al. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. , 2006, Human molecular genetics.
[37] M. Mulero,et al. Changes in oxidative stress parameters and neurodegeneration markers in the brain of the senescence-accelerated mice SAMP-8 , 2006, Experimental Gerontology.
[38] W. Müller,et al. Aging sensitizes toward ROS formation and lipid peroxidation in PS1M146L transgenic mice. , 2006, Free radical biology & medicine.
[39] O. Alvarez-Garcia,et al. Elevated Oxidative Stress in the Brain of Senescence-accelerated Mice at 5 Months of Age , 2006, Biogerontology.
[40] X. Chen,et al. Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease , 2005 .
[41] C. Meissner,et al. Lack of age-related increase of mitochondrial DNA amount in brain, skeletal muscle and human heart , 2005, Mechanisms of Ageing and Development.
[42] R. Ravid,et al. Proteomic and Functional Analyses Reveal a Mitochondrial Dysfunction in P301L Tau Transgenic Mice* , 2005, Journal of Biological Chemistry.
[43] R. Iida,et al. Quantitative change in mitochondrial DNA content in various mouse tissues during aging. , 2005, Biochimica et biophysica acta.
[44] K. Nair,et al. Decline in skeletal muscle mitochondrial function with aging in humans. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[45] Xi Chen,et al. ABAD enhances Aβ‐induced cell stress via mitochondrial dysfunction , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[46] C. Masters,et al. Copper-Dependent Inhibition of Human Cytochrome c Oxidase by a Dimeric Conformer of Amyloid-β1-42 , 2005, The Journal of Neuroscience.
[47] C. Haass,et al. Amyloid β-induced Changes in Nitric Oxide Production and Mitochondrial Activity Lead to Apoptosis* , 2004, Journal of Biological Chemistry.
[48] A. Eckert,et al. Age-related alteration of activity and gene expression of endothelial nitric oxide synthase in different parts of the brain in rats , 2004, Neuroscience Letters.
[49] J. Götz,et al. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models , 2004, International Journal of Developmental Neuroscience.
[50] M. Beal,et al. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[51] P. Reddy,et al. P3-291 Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage , 2004, Neurobiology of Aging.
[52] R. Martínez-Murillo,et al. Intra- and extracellular Abeta and PHF in clinically evaluated cases of Alzheimer's disease. , 2004, Histology and histopathology.
[53] J. Quinn,et al. Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. , 2004, Human molecular genetics.
[54] Ottavio Arancio,et al. Progressive age‐related development of Alzheimer‐like pathology in APP/PS1 mice , 2004, Annals of neurology.
[55] Xi Chen,et al. Materials and Methods Som Text Figs. S1 and S2 Table S1 References Abad Directly Links A to Mitochondrial Toxicity in Alzheimer's Disease , 2022 .
[56] T. Bayer,et al. Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice , 2003, Experimental Neurology.
[57] J. Kemp,et al. PS2APP Transgenic Mice, Coexpressing hPS2mut and hAPPswe, Show Age-Related Cognitive Deficits Associated with Discrete Brain Amyloid Deposition and Inflammation , 2003, The Journal of Neuroscience.
[58] M. Mattson,et al. Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.
[59] M. Chalimoniuk,et al. Activation of constitutive nitric oxide synthase(s) and absence of inducible isoform in aged rat brain , 2003, Neurochemistry International.
[60] V. Bohr,et al. Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells. , 2002, Free radical biology & medicine.
[61] E. Mandelkow,et al. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress , 2002, The Journal of cell biology.
[62] R. Nitsch,et al. Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils , 2001, Science.
[63] I. Scheffler,et al. A century of mitochondrial research: achievements and perspectives. , 2001, Mitochondrion.
[64] M. Kuro-o. Disease model: human aging. , 2001, Trends in molecular medicine.
[65] N. Sadato,et al. Age-Related Changes in Energy Production in Fresh Senescence-Accelerated Mouse Brain Slices as Revealed by Positron Autoradiography , 2001, Dementia and Geriatric Cognitive Disorders.
[66] O. Hazeki,et al. Age-related changes in manganese superoxide dismutase activity in the cerebral cortex of senescence-accelerated prone and resistant mouse , 2001, Neuroscience Letters.
[67] M. Onozuka,et al. Evidence for involvement of dysfunctional teeth in the senile process in the hippocampus of SAMP8 mice , 2001, Experimental Gerontology.
[68] R. Nitsch,et al. Tau Filament Formation in Transgenic Mice Expressing P301L Tau* , 2001, The Journal of Biological Chemistry.
[69] Guiquan Chen,et al. A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease , 2000, Nature.
[70] J. Morley,et al. β-Amyloid precursor polypeptide in SAMP8 mice affects learning and memory , 2000, Peptides.
[71] Hsiao-Wen Chen,et al. Unusual spectral energy distribution of a galaxy previously reported to be at redshift 6.68 , 2000, Nature.
[72] K. Nair,et al. Effects of Aging on Mitochondrial DNA Copy Number and Cytochromec Oxidase Gene Expression in Rat Skeletal Muscle, Liver, and Heart* , 2000, The Journal of Biological Chemistry.
[73] G. Drewes,et al. Phosphorylation of MAP2c and MAP4 by MARK kinases leads to the destabilization of microtubules in cells. , 1999, Cell motility and the cytoskeleton.
[74] Steven G. Clarke,et al. Role of ERAB/l-3-Hydroxyacyl-coenzyme A Dehydrogenase Type II Activity in Aβ-induced Cytotoxicity* , 1999, The Journal of Biological Chemistry.
[75] Xi Chen,et al. An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease , 1997, Nature.
[76] L. Mucke,et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.
[77] J. Kimura,et al. Beta/A4 proteinlike immunoreactive granular structures in the brain of senescence-accelerated mouse. , 1993, The American journal of pathology.
[78] Yau-Huei Wei,et al. Ageing-associated 5 kb deletion in human liver mitochondrial DNA. , 1991, Biochemical and biophysical research communications.
[79] Xiaoliang Wang,et al. Strain- and age-related alteration of proteins in the brain of SAMP8 and SAMR1 mice. , 2011, Journal of Alzheimer's disease : JAD.
[80] R. Swerdlow,et al. Polymorphic variation in cytochrome oxidase subunit genes. , 2010, Journal of Alzheimer's disease : JAD.
[81] N. Schonrock,et al. Is tau aggregation toxic or protective: a sensible question in the absence of sensitive methods? , 2008, Journal of Alzheimer's disease : JAD.
[82] G. Perry,et al. From aging to Alzheimer's disease: unveiling "the switch" with the senescence-accelerated mouse model (SAMP8). , 2008, Journal of Alzheimer's disease : JAD.
[83] M. Staufenbiel,et al. Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice. , 2007, The American journal of pathology.
[84] X. Chen,et al. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[85] N. Tumosa,et al. Beta-amyloid precursor polypeptide in SAMP8 mice affects learning and memory. , 2000, Peptides.
[86] Jada Lewis. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein , 2000, Nature Genetics.
[87] J. Blass,et al. Abnormalities of mitochondrial enzymes in Alzheimer disease , 1998, Journal of Neural Transmission.
[88] Xiaomin Song,et al. Amyloid- (cid:1) and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer’s disease mice , 2009 .